Related Concept Videos
Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Open Angle Glaucoma: Treatment
811
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
811
Angle Closure Glaucoma: Treatment
938
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
938
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same journal
Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease.
Eye (London, England)·2026
Same journal
Oculomics and the NHS: A UK opportunity to translate eye-derived biomarkers into population health.
Eye (London, England)·2026
Same journal
Long-term follow-up and outcomes of a Diabetic Eye Screening Programme in patients aged 80 with no diabetic eye disease at baseline: should we be routinely screening this cohort?
Eye (London, England)·2026
Same journal
Real world experience with faricimab in switched neovascular AMD and evaluation of reloading versus interval matching regimes.
Eye (London, England)·2026
Same journal
"When the lens drew a continent: a cartographic clue to Alport syndrome".
Eye (London, England)·2026
Same journal
Infographic: efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity.
Eye (London, England)·2026


